Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Orexo===AmorphOX
Entity

Orexo===AmorphOX

Tracked across 2 events · 15 articles · First seen Mar 06, 2026 · Last active Mar 06, 2026

Sentiment
22
Attention
2
Events
2
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
2 30
Business
Orexo R&D Day on Strategy and AmorphOX
Orexo===AmorphOX is Orexo's proprietary drug delivery technology, central to its future development focus and pipeline, including Orexo===OX640 and Orexo===OX390.
Mar 06, 2026 · 7 articles
2 15
Business
Orexo Restructures Management, Appoints Lisa Moore
Orexo aims to unlock the potential of its proprietary Orexo===AmorphOX technology, which is central to its innovation in drug delivery.
Mar 06, 2026 · 8 articles
Relationships (4)
Orexo proprietary technology ↔ Orexo===AmorphOX Orexo===AmorphOX is a proprietary drug delivery technology at the core of Orexo'
Nikolaj Sørensen ↔ Orexo===AmorphOX Unknown
Orexo===OX390 ↔ Orexo===AmorphOX Unknown
Orexo===OX640 ↔ Orexo===AmorphOX Unknown
NEWSDESK
Track Orexo===AmorphOX live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.